Triomics
company
About
Technology-powered high-quality Clinical Trials
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $2.88M
- Industries
- Internet,Software
- Founded date
- Jan 1, 2020
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Triomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.88M
Triomics has raised a total of
$2.88M
in funding over 2 rounds. Their latest funding was raised on
Nov 24, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 24, 2021 | Seed | $2.88M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Triomics is funded by 1 investors.
General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
General Catalyst
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
